(Q35653703)
Statements
How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development? (English)
Rogier W Sanders
John P Moore
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference